Novartis Offers High-Grade Debt to Fund $12 billion Avidity Deal

Novartis AG is seeking to raise debt to help fund its $12 billion acquisition of Avidity Biosciences Inc, adding to a flurry of M&A financing deals....

Redirecting to full article...